These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8559506)

  • 1. Metastatic renal-cell carcinoma developing in two recipients of renal grafts derived from the same donor.
    Kooistra MP; Vos PF; de Graaf PW; Gmelig-Meyling FH; de Graeff A; Lock TM; de Gast GC; Vroom TM; Hené RJ
    Nephrol Dial Transplant; 1995; 10(9):1772-4. PubMed ID: 8559506
    [No Abstract]   [Full Text] [Related]  

  • 2. Metastatic RCC arising in a transplant kidney.
    Kunisch-Hoppe M; Hoppe M; Bohle RM; Rauber K; Weimar B; Friemann S; Stahl U; Rau WS
    Eur Radiol; 1998; 8(8):1441-3. PubMed ID: 9853232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic renal-cell carcinoma: what causes occasional dramatic regressions?
    Young RC
    N Engl J Med; 1998 Apr; 338(18):1305-6. PubMed ID: 9562587
    [No Abstract]   [Full Text] [Related]  

  • 4. Donor-origin cancer in renal transplant recipients from deceased donors: worth gambling?
    Moris D; Dounousi E; Zavos G
    Transpl Int; 2015 Feb; 28(2):253-4. PubMed ID: 25181948
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination biologic therapy with interleukin-2 and interferon-alfa in the outpatient treatment of metastatic renal cell carcinoma.
    Figlin RA; Pierce WC; Belldegrun A
    Semin Oncol; 1993 Dec; 20(6 Suppl 9):11-5. PubMed ID: 8284686
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoimmunity resulting from cytokine treatment predicts long-term survival in patients with metastatic renal cell cancer.
    Franzke A; Peest D; Probst-Kepper M; Buer J; Kirchner GI; Brabant G; Kirchner H; Ganser A; Atzpodien J
    J Clin Oncol; 1999 Feb; 17(2):529-33. PubMed ID: 10080596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination recombinant interleukin-2, recombinant interferon-alpha, and 5-fluorouracil for treatment of metastatic renal cell carcinoma.
    Ueno NT; Zukiwski AA
    Am J Clin Oncol; 1995 Aug; 18(4):358-62. PubMed ID: 7625380
    [No Abstract]   [Full Text] [Related]  

  • 8. [Has interleukin 2 modified the outcome of metastatic kidney cancer?].
    Négrier S; Philip T
    Ann Urol (Paris); 1993; 27(2):87-9. PubMed ID: 8503657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of immunotherapy in metastatic cancer of the kidney].
    Thiounn N
    J Urol (Paris); 1994; 100(5):231-7. PubMed ID: 7730669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic renal carcinoma in a pediatric recipient of an adult cadaveric donor kidney.
    Lotan D; Laufer J
    Am J Kidney Dis; 1995 Dec; 26(6):960-2. PubMed ID: 7503073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European studies of interleukin-2 in metastatic renal cell carcinoma.
    Atzpodien J; Kirchner H; Hänninen EL; Körfer A; Fenner M; Menzel T; Deckert M; Franzke A; Jonas U; Poliwoda H
    Semin Oncol; 1993 Dec; 20(6 Suppl 9):22-6. PubMed ID: 8284688
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal cell carcinoma of the grafted kidney: how to improve screening and graft tracking.
    Rouprêt M; Peraldi MN; Thaunat O; Chrétien Y; Thiounn N; Dufour B; Kreis H; Méjean A
    Transplantation; 2004 Jan; 77(1):146-8. PubMed ID: 14724453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine therapy in metastatic renal cancer.
    Jerian S; Keegan P; Siegel J
    N Engl J Med; 1998 Sep; 339(12):849-50; author reply 850. PubMed ID: 9750083
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chances for the success of cytokine therapy in metastatic renal cell cancer].
    Kriegmair M
    Fortschr Med; 1992 Aug; 110(24):435-6. PubMed ID: 1398389
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant treatment with IL-2 or interferon-alpha in renal cell carcinoma: a French multicentric study.
    Soret JY; Escudier B
    Cancer Biother Radiopharm; 1996 Oct; 11(5):301-2. PubMed ID: 10851508
    [No Abstract]   [Full Text] [Related]  

  • 16. Present achievements in the medical treatment of metastatic renal cell carcinoma.
    Ravaud A; Debled M
    Crit Rev Oncol Hematol; 1999 Jun; 31(1):77-87. PubMed ID: 10532192
    [No Abstract]   [Full Text] [Related]  

  • 17. Metastatic Renal Cell Carcinoma in a Renal Allograft: A Sustained Complete Remission After Stimulated Rejection.
    Champion L; Culine S; Desgranchamps F; Benali K; Verine J; Daugas E
    Am J Transplant; 2017 Apr; 17(4):1125-1128. PubMed ID: 27931087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current clinical practice of induction and maintenance immunotherapy for metastatic renal cell carcinoma.
    Little B; Young M; Ho KJ
    Int J Clin Pract; 2002; 56(1):36-9. PubMed ID: 11831831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative tumor board: metastatic renal cell carcinoma: medical oncology (II).
    Pandha H
    Integr Cancer Ther; 2004 Mar; 3(1):29-34. PubMed ID: 15035872
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal cell carcinomas of donor origin in two kidney transplants from a single donor.
    Heinz-Peer G; Helbich T; Barnas U; Mayer G; Mühlbacher F; Mostbeck GH
    Transplantation; 1995 Mar; 59(6):912-3. PubMed ID: 7701592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.